<b>Background/Objectives</b>: Contralateral breast cancer (CBC) is a significant concern among breast cancer survivors, particularly in those with moderator-high penetrance germline mutations such as BRCA1, BRCA2, CHEK2, and ATM. The gene discussed is CHEK2; the disease is complete blood cell count.